Results 41 to 50 of about 3,650 (207)

Injectable Contraceptive Use in Women With Intellectual Disability – A Narrative Review and Local Case Series

BJPsych Open
Aims: Intellectual Disability is defined as an IQ below 71. People with intellectual disability frequently experience menstrual distress leading to use of hormonal medications such as depot medroxyprogesterone acetate (DMPA).
Marianne Bergman, Alaa Martin
doaj   +1 more source

Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi

mSphere, 2023
Important questions remain on how hormonal contraceptives alter the local immune environment and the microbiota in the female genital tract and how such effects may impact susceptibility to HIV infection.
Lisa B. Haddad, Jennifer H. Tang, Nicole L. Davis, Athena P. Kourtis, Lameck Chinula, Albans Msika, Gerald Tegha, Mina C. Hosseinipour, Julie A. E. Nelson, Marcia M. Hobbs, Pawel Gajer, Jacques Ravel, Kristina De Paris   +12 more
doaj   +1 more source

Membranous dysmenorrhea and decidual casts: A scoping review

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley   +1 more source

Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood

Reproductive Biology and Endocrinology, 2019
Background Hormonal contraceptives, particularly depot medroxyprogesterone acetate (DMPA), have been reported to be associated with substantially enhanced HIV acquisition; however, the biological mechanisms of this risk remain poorly understood. We aimed
Liping Li, Jie Zhou, Weijia Wang, Lina Huang, Jiaoqin Tu, Lyndsey Baiamonte, Moselle Stark, Mistie Mills, Thomas J. Hope, Erma Z. Drobnis, Alison J. Quayle, Danny J. Schust   +11 more
doaj   +1 more source

Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate By Adolescent Women [PDF]

Journal of Adolescent Health, 2010
Intramuscular depot medroxyprogesterone acetate (DMPA-IM) is now available in subcutaneous (SC) formulation, potentially allowing for home-based self-administration. We examined adolescents' interest in and proficiency at DMPA-SC self-administration.This is a planned secondary analysis of a randomized controlled trial comparing pain between DMPA-IM and
Rebekah L, Williams, Devon J, Hensel, J Dennis, Fortenberry   +2 more
openaire   +2 more sources

State Choices, Unequal Access: Policies Shaping Reproductive Health Care Across the United States

The Milbank Quarterly, EarlyView.
Policy Points State policies and programs play an outsized role in shaping availability and access to sexual and reproductive health services across the nation. This has a major impact on women's access to contraception, abortion, and maternity services.
ALINA SALGANICOFF, IVETTE GOMEZ, USHA RANJI   +2 more
wiley   +1 more source

Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong, Sarah Hillman, Sharon Dixon, Anupa Shah, Radha Venkatakrishnan, Jeremy W. Tomlinson   +5 more
wiley   +1 more source

Provision of injectable contraceptives by community health workers in sub-Saharan Africa: a systematic review of safety, acceptability and effectiveness

Human Resources for Health, 2022
Background Injectable contraceptives are the most popular method of contraception in sub-Saharan Africa (SSA), but their availability in clinical settings has been severely limited, despite the scarcity of health care providers and limited access to ...
Besong Eric Ayuk, Brenda Mbouamba Yankam, Farrukh Ishaque Saah, Luchuo Engelbert Bain   +3 more
doaj   +1 more source

Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate‐to‐Severe Endometriosis Pain: A Phase III, Multicentric, Double‐Blind, Active‐Controlled, Non‐Inferiority Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To compare the efficacy, safety and tolerability of elagolix with dienogest in women with moderate‐to‐severe endometriosis‐associated pain. Design A multicentre, double‐blind, double‐dummy, randomised, parallel‐group, active‐controlled, non‐inferiority phase III study. Setting Nineteen clinical centres across India.
Sneha Bhoir, Jaldhara Patel, Tushar Palve, Mrinal Kanti Dash, Sweety Saigal, Gourisankar Kamilya, Shalini Srivastava, Kartikbhai Savalia, Tanusree Gupta, Deepa Choudhary, Manohar Rangaswamy, Vidya V Bhatt, Neena Gupta, Malathi Ponnuru, Parul Shah, Apurva Shetty, Shruti Saha, Reshma Quadros, Sucheta Pandit, Dipak Patil, Piyush Patel, Pravin Ghadge, Lalit Lakhwani, Suyog Mehta, Sadhana Joglekar   +24 more
wiley   +1 more source

Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate.

PLoS ONE, 2020
BackgroundThe ECHO trial has relieved apprehension about intramuscular depot medroxyprogesterone acetate (DMPA-IM), however it is still important to understand how DMPA-IM affects the vaginal environment.
Bridget M Whitney, Brandon L Guthrie, Sujatha Srinivasan, Kenneth Tapia, Eric Munene Muriuki, Bhavna H Chohan, Jacqueline M Wallis, Congzhou Liu, R Scott McClelland, David N Fredricks, Alison C Roxby   +10 more
doaj   +1 more source